Document:

Exhibit 10.4

   

  REGISTRATION
        AND STOCKHOLDER RIGHTS AGREEMENT

   

  THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT
    (this “Agreement”), dated as of December 8, 2020, is made and entered into by and among HumanCo Acquisition
    Corp., a Delaware corporation (the “Company”), HumanCo Acquisition Holdings, LLC, a Delaware limited
    liability company (the “Sponsor”), HMCO Acquisition, LLC (“HumanCo SPV”), CAVU
    Venture Partners III, LP (“CAVU”) and the other undersigned parties listed under Holder on the signature
    page hereto (each such party, together with the Sponsor, CAVU and any person or entity who hereafter becomes a party to this Agreement
    pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).

   

  RECITALS

   

  WHEREAS, the Company and the Sponsor
    have entered into that certain Securities Subscription Agreement, dated as of October 12, 2020, pursuant to which the Sponsor purchased
    an aggregate of 6,468,750 shares of the Company’s Class B common stock, par value $0.0001 per share (the “Class
        B Common Stock”);

   

  WHEREAS, in November 2020, the Sponsor
    transferred (i) 25,000 shares of Class B Common Stock to each of Kat Cole, John Foraker, Dean Hollis and Brian Kelley, the Company’s
    independent directors, (ii) 75,000 shares of Class B Common Stock to Ross Berman, (iii) 25,000 shares of Class B Common Stock to
    Amy Zipper and (iv) 10,000 shares of Class B Common Stock to Brian Locklear;

   

  WHEREAS, on December 8, 2020, the Company
    declared a stock dividend (the “Dividend”) with respect to the Class B Common Stock of 718,750 shares
    (up to 93,750 shares of which are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’
    option to purchase additional units is exercised), and each of the Company’s independent directors, Ross Berman, Amy Zipper
    and Brian Locklear renounced any interest in such Dividend on December 8, 2020, resulting in (i) the Sponsor holding an aggregate
    of 6,977,500 shares of Class B Common Stock (up to 937,500 of which were subject to forfeiture by the Sponsor depending on the
    extent to which the underwriters’ option to purchase additional units is exercised) and (ii) there being an aggregate of
    7,187,500 shares of Class B Common Stock outstanding (the “Founder Shares”);

   

  WHEREAS, the Founder Shares are convertible
    into shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”),
    on a one-for-one basis, subject to adjustment, on the terms and conditions provided in the Company’s amended and restated
    certificate of incorporation, as may be amended from time to time;

   

  WHEREAS, on December 8, 2020, the Company
    and the Sponsor entered into that certain Warrant Purchase Agreement, pursuant to which the Sponsor agreed to purchase 7,325,000
    warrants (or up to 8,075,000 warrants if the over-allotment option in connection with the Company’s initial public offering
    is exercised in full) (together with all other warrants issued by the Company to the Sponsor on substantially the same terms, including
    warrants that may be issued upon conversion of working capital loans, the “Private Placement Warrants”),
    in a private placement transaction occurring simultaneously with the closing of the Company’s initial public offering, each
    Private Placement Warrant entitling the holder to purchase one share of Common Stock at an exercise price of $11.50 per share;

   

  WHEREAS, on December 8, 2020, the Company
    and CAVU entered into that certain Unit Purchase Agreement, pursuant to which CAVU agreed to purchase 2,500,000 units (regardless
    of whether the over-allotment option in connection with the Company’s initial public offering is exercised) (the “CAVU
        Units”), in a private placement transaction occurring simultaneously with the closing of the Company’s initial
    public offering, each CAVU Unit consisting of one share of Common Stock (the “CAVU Shares”) and a fraction
    of a warrant (the “CAVU Warrants”);

   

  WHEREAS, in order to finance the Company’s
    transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of
    the Sponsor or certain of the Company’s officers and directors may loan to the Company funds as the Company require, of which
    up to $2,000,000 of such loans may be convertible into warrants (“Working Capital Warrants”) at a price
    of $1.00 per warrant; and

   

  
  
    	 

  

  
     

  

  
    

  WHEREAS, the Company and the Holders
    desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect
    to certain securities of the Company, as set forth in this Agreement.

   

  NOW, THEREFORE, in consideration
    of the mutual representations, covenants and agreements contained herein, and certain other good and valuable consideration, the
    receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

   

  ARTICLE
        I

        DEFINITIONS

   

  1.1 Definitions. The terms defined in
    this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

   

  “Adverse Disclosure”
    shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief
    Executive Officer or the principal financial officer of the Company, after consultation with counsel to the Company, (i) would
    be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus
    not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained
    therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were
    made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and
    (iii) the Company has a bona fide business purpose for not making such information public.

   

  “Agreement” shall
    have the meaning given in the Preamble.

   

  “Board” shall mean
    the Board of Directors of the Company.

   

  “Business Combination”
    shall mean any merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination
    with one or more businesses, involving the Company.

   

  “CAVU” shall have
    the meaning given in the Preamble.

   

  “CAVU Shares” shall
    have the meaning given in the Recitals hereto.

   

  “CAVU Units” shall
    have the meaning given in the Recitals hereto.

   

  “CAVU Warrants” shall
    have the meaning given in the Recitals hereto.

   

  “Class B Common Stock”
    shall have the meaning given in the Recitals hereto.

   

  “Commission” shall
    mean the U.S. Securities and Exchange Commission.

   

  “Common Stock” shall
    have the meaning given in the Recitals hereto.

   

  “Company” shall have
    the meaning given in the Preamble.

   

  “Demand Registration”
    shall have the meaning given in subsection 2.1.1.

   

  “Demanding Holder”
    shall have the meaning given in subsection 2.1.1.

   

  “Exchange Act” shall
    mean the Securities Exchange Act of 1934, as amended.

   

  “Form S-1” shall have
    the meaning given in subsection 2.1.1.

   

  “Form S-3” shall have
    the meaning given in subsection 2.3.

   

  
  
    	 

  

  
     

  

  
    

  “Founder Shares” shall
    have the meaning given in the Recitals hereto and shall be deemed to include the shares of Common Stock issuable upon conversion
    thereof.

   

  “Founder Shares and CAVU Shares
        Lock-Up Period” shall mean, with respect to the Founder Shares and the CAVU Shares, the period ending on the earlier
    of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s
    initial Business Combination, (x) if the last reported sale price of the Common Stock equals or exceeds $12.00 per share (as adjusted
    for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading
    day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date on which the Company
    completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the
    Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other property.

   

  “Holders” shall have
    the meaning given in the Preamble.

   

  “HumanCo SPV” shall
    have the meaning given in the Preamble.

   

  “Insider Letter” shall
    mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor, each of the Company’s
    executive officers and directors, CAVU, HumanCo SPV and certain other parties thereto.

   

  “Maximum Number of Securities”
    shall have the meaning given in subsection 2.1.4.

   

  “Misstatement” shall
    mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
    or Prospectus, or necessary to make the statements in a Registration Statement not misleading or, in the case of a Prospectus,
    not misleading in the light of the circumstances under which they were made.

   

  “Nominee” shall have
    the meaning given in subsection 5.1.1.

   

  “Observer” shall have
    the meaning given in Section 5.2.

   

  “Permitted Transferees”
    shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities
    prior to the expiration of the Founder Shares and CAVU Shares Lock-Up Period or Private Placement Lock-Up Period, as the case may
    be, under the Insider Letter and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.

   

  “Piggyback Registration”
    shall have the meaning given in subsection 2.2.1.

   

  “Private Placement and CAVU Warrants
        Lock-Up Period” shall mean, with respect to Private Placement Warrants and CAVU Warrants that are held by the initial
    purchasers of such Private Placement Warrants, CAVU Warrants or their respective Permitted Transferees and any of the shares of
    Common Stock issued or issuable upon the exercise or conversion of the Private Placement Warrants and CAVU Warrants and that are
    held by the initial purchasers of the Private Placement Warrants, CAVU Warrants or their respective Permitted Transferees, the
    period ending 30 days after the completion of the Company’s initial Business Combination.

   

  “Private Placement Warrants”
    shall have the meaning given in the Recitals hereto.

   

  “Pro Rata” shall have
    the meaning given in subsection 2.1.4.

   

  “Prospectus” shall
    mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
    by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

   

  
  
    	 

  

  
     

  

  
    

  “Registrable Security”
    shall mean (a) the Founder Shares and the shares of Common Stock issued or issuable upon the conversion of any Founder Shares,
    (b) the CAVU Shares, (c) the Private Placement Warrants (including any shares of Common Stock issued or issuable upon the exercise
    of any such Private Placement Warrants), (d) the CAVU Warrants (including any shares of Common Stock issued or issuable upon the
    exercise of any such CAVU Warrants), (e) any outstanding shares of Common Stock or any other equity security (including the shares
    of Common Stock issued or issuable upon the exercise or conversion of any other equity security) of the Company held by a Holder
    as of the date of this Agreement, (f) any Working Capital Warrant (including the shares of Common Stock issued or issuable upon
    the exercise of any such Working Capital Warrant), and (g) any other equity security of the Company issued or issuable with respect
    to any of the securities described in the foregoing clauses (a) – (f) by way of a stock dividend or stock split or in connection
    with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that,
    as to any particular Registrable Security, such security shall cease to be a Registrable Security when: (A) a Registration Statement
    with respect to the sale of such security shall have become effective under the Securities Act and such security shall have been
    sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such security shall have been otherwise
    transferred, new certificates for such security not bearing a legend restricting further transfer shall have been delivered by
    the Company and subsequent public distribution of such security shall not require registration under the Securities Act; (C) such
    security shall have ceased to be outstanding; (D) such security may be sold without registration pursuant to Rule 144 promulgated
    under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions
    or limitations); or (E) such security has been sold to, or through, a broker, dealer or underwriter in a public distribution or
    other public securities transaction.

   

  “Registration” shall
    mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
    of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
    effective.

   

  “Registration Expenses”
    shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

   

  (A) all registration and filing fees (including
    fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange
    on which the Common Stock is then listed;

   

  (B) fees and expenses of compliance with securities
    or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications
    of Registrable Securities);

   

  (C) printing, messenger, telephone and delivery
    expenses;

   

  (D) reasonable fees and disbursements of counsel
    for the Company;

   

  (E) reasonable fees and disbursements of all
    independent registered public accountants of the Company incurred specifically in connection with such Registration; and

   

  (F) reasonable fees and expenses of one (1)
    legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration to be registered for
    offer and sale in the applicable Registration.

   

  “Registration Statement”
    shall mean any registration statement filed by the Company with the Commission in compliance with the Securities Act and the rules
    and regulations promulgated thereunder (other than a Registration Statement on Form S-4 or Form S-8, or their successors), which
    registration statement covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus
    included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
    statement, and all exhibits to and all material incorporated by reference in such registration statement.

   

  “Requesting Holder”
    shall have the meaning given in subsection 2.1.1.

   

  
  
    	 

  

  
     

  

  
    

  “Securities Act” shall
    mean the Securities Act of 1933, as amended.

   

  “Sponsor” shall have
    the meaning given in the Preamble.

   

  “Sponsor Director”
    means an individual elected to the Board that has been nominated pursuant to Section 5.1.

   

  “Underwriter” shall
    mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
    dealer’s market-making activities.

   

  “Underwritten Registration”
    or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an
    Underwriter in a firm commitment underwriting for distribution to the public.

   

  “Working Capital Warrants”
    shall have the meaning given in the Recitals hereto.

   

  ARTICLE
        II

  REGISTRATIONS

   

  2.1 Demand Registration.

   

  2.1.1 Request for Registration. Subject
    to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time to time on or after the date
    the Company consummates a Business Combination, HumanCo SPV, CAVU or their respective Permitted Transferees (the “Demanding
        Holders”) may make a written demand for Registration of all or part of their Registrable Securities, which written
    demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of distribution
    thereof (such written demand a “Demand Registration”). The Company shall, within ten (10) days of the
    Company’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand,
    and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable
    Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s
    Registrable Securities in such Registration, a “Requesting Holder”) shall so notify the Company, in writing,
    within five (5) days after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written
    notification from a Requesting Holder(s), such Requesting Holder(s) shall be entitled to have their Registrable Securities included
    in a Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more
    than forty five (45) days immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable
    Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances
    shall the Company be obligated to effect more than an aggregate of three (3) Registrations pursuant to a Demand Registration under
    this subsection 2.1.1 with respect to any or all Registrable Securities; provided, however, that a Registration
    shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may be available
    at such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the
    Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance
    with Section 3.1 of this Agreement.

   

  2.1.2 Effective Registration. Notwithstanding
    the provisions of subsection 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration
    shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration
    pursuant to the Demand Registration has been declared effective by the Commission and (ii) the Company has complied with all of
    its obligations under this Agreement with respect thereto; provided, further, that if, after such Registration Statement
    has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is interfered
    with by any stop order or injunction of the Commission, federal or state court or any other governmental agency the Registration
    Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop
    order or injunction is removed, rescinded or otherwise terminated and (ii) the Demanding Holders initiating such Demand Registration
    thereafter affirmatively elect within five (5) days to continue with such Registration and accordingly notify the Company in writing
    of such election within such five (5)-day period; provided, further, that the Company shall not be obligated or required
    to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration
    pursuant to a Demand Registration becomes effective or is subsequently terminated.

   

  
  
    	 

  

  
     

  

  
    

  2.1.3 Underwritten Offering. Subject to
    the provisions of subsection 2.1.4 and Section 2.4 hereof, if a Demanding Holder so advises the Company as part of
    its Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form
    of an Underwritten Offering, then the right of each Demanding Holder or Requesting Holder (if any) to include its Registrable Securities
    in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion
    of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided herein. All such Holders proposing
    to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.1.3 shall enter into
    an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Demanding Holders
    initiating the Demand Registration.

   

  2.1.4 Reduction of Underwritten Offering.
    If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises
    the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable
    Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Common
    Stock or other equity securities that the Company desires to sell and the Common Stock or other equity securities, if any, as to
    which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other
    stockholders of the Company who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can
    be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method,
    or the probability of success of the Underwritten Offering (such maximum dollar amount or maximum number of such securities, as
    applicable, the “Maximum Number of Securities”), then the Company shall include in such Underwritten
    Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata
    based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested
    be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and
    Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro
        Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the
    Maximum Number of Securities has not been reached under the foregoing clause (i), the Common Stock or other equity securities that
    the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii) third, to the extent
    that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Common Stock or other
    equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to separate
    written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.

   

  2.1.5 Demand Registration Withdrawal. A
    Demanding Holder initiating a Demand Registration or a Requesting Holder (if any) pursuant to a Registration under subsection
      2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever
    upon written notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such
    Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration
    of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement,
    the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand
    Registration prior to its withdrawal under this subsection 2.1.5.

   

  
  
    	 

  

  
     

  

  
    

  2.2 Piggyback Registration.

   

  2.2.1 Piggyback Rights. If, at any time
    on or after the date the Company consummates a Business Combination, the Company proposes to file a Registration Statement under
    the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable
    for, or convertible into equity securities, for its own account or for the account of stockholders of the Company (or by the Company
    and by the stockholders of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration
    Statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or offering
    of securities solely to the Company’s existing stockholders, (iii) for an offering of debt that is convertible into equity
    securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of such proposed
    filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated
    filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in
    such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any,
    in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number
    of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such
    Registration, a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities
    to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter or Underwriters
    of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection
      2.2.1 to be included in such Piggyback Registration on the same terms and conditions as any similar securities of the Company
    included in such Piggyback Registration and to permit the sale or other disposition of such Registrable Securities in accordance
    with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through
    an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the
    Underwriter(s) selected for such Underwritten Offering by the Company.

   

  2.2.2 Reduction of Piggyback Registration.
    If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith,
    advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar
    amount or number of the securities that the Company desires to sell, taken together with (i) the Common Stock or other equity securities,
    if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities
    other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested
    pursuant to Section 2.2 hereof, and (iii) the Common Stock or other equity securities, if any, as to which Registration
    has been requested pursuant to separate written contractual piggy-back registration rights of other stockholders of the Company,
    exceeds the Maximum Number of Securities, then:

   

  (a) If the Registration is undertaken for the
    Company’s account, the Company shall include in any such Registration (A) first, the Common Stock or other equity securities
    that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent
    that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders
    exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata, which can
    be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities
    has not been reached under the foregoing clauses (A) and (B), the Common Stock, if any, as to which Registration has been requested
    pursuant to written contractual piggy-back registration rights of other stockholders of the Company, which can be sold without
    exceeding the Maximum Number of Securities;

   

  (b) If the Registration is pursuant to a request
    by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration
    (A) first, the Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders
    of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that
    the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising
    their rights to register their Registrable Securities pursuant to subsection 2.2.1, Pro Rata, which can be sold without
    exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached
    under the foregoing clauses (A) and (B), the Common Stock or other equity securities that the Company desires to sell, which can
    be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities
    has not been reached under the foregoing clauses (A), (B) and (C), the Common Stock or other equity securities for the account
    of other persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements with
    such persons or entities, which can be sold without exceeding the Maximum Number of Securities.

   

  2.2.3 Piggyback Registration Withdrawal.
    Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever
    upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw
    from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect
    to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal
    by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission
    in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding
    anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection
    with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

   

  
  
    	 

  

  
     

  

  
    

  2.2.4 Unlimited Piggyback Registration Rights.
    For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration
    pursuant to a Demand Registration effected under Section 2.1 hereof.

   

  2.3 Registrations on Form S-3. The Holders
    of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415 under
    the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their
    Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form
        S-3”); provided, however, that the Company shall not be obligated to effect such request through an Underwritten
    Offering. Within five (5) days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities
    for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration on Form S-3 to all
    other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion
    of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing, within
    ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than
    twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company
    shall register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together
    with all or such portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the
    written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any
    such Registration pursuant to this Section 2.3 if (i) a Form S-3 is not available for such offering; or (ii) the Holders
    of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such
    Registration, propose to sell the Registrable Securities and such other equity securities (if any) at any aggregate price to the
    public of less than $10,000,000.

   

  2.4 Restrictions on Registration Rights.
    If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of
    the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration
    and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to
    subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration
    Statement to become effective; (B) the Holders have requested an Underwritten Registration and the Company and the Holders are
    unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board
    such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer
    the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate
    signed by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the
    Company for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of
    such Registration Statement. In such event, the Company shall have the right to defer such filing for a period of not more than
    thirty (30) days; provided, however, that the Company shall not defer its obligation in this manner more than once in any 12-month
    period. Notwithstanding anything to the contrary contained in this Agreement, no Registration shall be effected or permitted and
    no Registration Statement shall become effective, with respect to any Registrable Securities held by any Holder, until after the
    expiration of the Founder Shares and CAVU Shares Lock-Up Period or the Private Placement and CAVU Warrants Lock-Up Period, as the
    case may be.

   

  ARTICLE
        III

        COMPANY PROCEDURES

   

  3.1 General Procedures. If at any time
    on or after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable
    Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities
    in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

   

  
  
    	 

  

  
     

  

  
    

  3.1.1 prepare and file with the Commission as
    soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts to
    cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration
    Statement have been sold;

   

  3.1.2 prepare and file with the Commission such
    amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably
    requested by any Holder or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions
    applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the
    Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance
    with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

   

  3.1.3 prior to filing a Registration Statement
    or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and each Holder of Registrable
    Securities included in such Registration, and each such Holder’s legal counsel, copies of such Registration Statement as
    proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto
    and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary
    Prospectus), and such other documents as the Underwriters and each Holder of Registrable Securities included in such Registration
    or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned
    by such Holders;

   

  3.1.4 prior to any public offering of Registrable
    Securities, use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under
    such securities or “blue sky” laws of such jurisdictions in the United States as any Holder of Registrable Securities
    included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action
    necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such
    other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other
    acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration
    Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
    that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be
    required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction
    where it is not then otherwise so subject;

   

  3.1.5 cause all such Registrable Securities to
    be listed on each securities exchange or automated quotation system on which similar securities issued by the Company are then
    listed;

   

  3.1.6 provide a transfer agent or warrant agent,
    as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

   

  3.1.7 advise each seller of such Registrable Securities,
    promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending
    the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly
    use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should
    be issued;

   

  3.1.8 at least five (5) days prior to the filing
    of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any
    document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each
    seller of such Registrable Securities and its counsel, including, without limitation, providing copies promptly upon receipt of
    any comment letters received with respect to any such Registration Statement or Prospectus;

   

  3.1.9 notify the Holders at any time when a Prospectus
    relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as
    a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then
    to correct such Misstatement as set forth in Section 3.4 hereof;

   

  
  
    	 

  

  
     

  

  
    

  3.1.10 permit a representative of the Holders
    (such representative to be selected by a majority of the participating Holders), the Underwriters, if any, and any attorney or
    accountant retained by such Holders or Underwriter to participate, at each such person’s own expense, in the preparation
    of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information reasonably
    requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,
    however, that such representative or Underwriters enter into a confidentiality agreement, in form and substance reasonably
    satisfactory to the Company, prior to the release or disclosure of any such information; and provided further, the Company
    may not include the name of any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration
    Statement or Prospectus, any amendment or supplement to such Registration Statement or Prospectus, any document that is to be incorporated
    by reference into such Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent
    of such Holder or Underwriter and providing each such Holder or Underwriter a reasonable amount of time to review and comment on
    such applicable document, which comments the Company shall include unless contrary to applicable law;

   

  3.1.11 obtain a “cold comfort” letter
    from the Company’s independent registered public accountants in the event of an Underwritten Registration, in customary form
    and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may
    reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

   

  3.1.12 on the date the Registrable Securities
    are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for
    the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters,
    if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders,
    placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative
    assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

   

  3.1.13 in the event of any Underwritten Offering,
    enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter
    of such offering;

   

  3.1.14 make available to its security holders,
    as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the
    first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies
    the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by
    the Commission);

   

  3.1.15 if the Registration involves the Registration
    of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable efforts to make available senior
    executives of the Company to participate in customary “road show” presentations that may be reasonably requested by
    the Underwriter in any Underwritten Offering; and

   

  3.1.16 otherwise, in good faith, cooperate reasonably
    with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.

   

  3.2 Registration Expenses. The Registration
    Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all
    incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts,
    brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,”
    all reasonable fees and expenses of any legal counsel representing the Holders.

   

  3.3 Requirements for Participation in Underwritten
      Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration
    initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in
    any underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney,
    indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under the
    terms of such underwriting arrangements.

   

  
  
    	 

  

  
     

  

  
    

  3.4 Suspension of Sales; Adverse Disclosure.
    Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the
    Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a supplemented
    or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such
    supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is advised in writing by
    the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration
    Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would require the
    inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s
    control, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness
    of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days,
    determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under the
    preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of
    the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company shall
    immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.4,
    and upon the expiration of such period, the Holders shall be entitled to resume the use of any such Prospectus in connection with
    any sale or offer to sell Registrable Securities.

   

  3.5 Reporting Obligations. As long as
    any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange
    Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports
    required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly
    furnish the Holders with true and complete copies of all such filings. The Company further covenants that it shall take such further
    action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares
    of the Common Stock held by such Holder without registration under the Securities Act within the limitation of the exemptions provided
    by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing
    any legal opinions, to the extent such exemption is available to Holders at such time. Upon the request of any Holder, the Company
    shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

   

  ARTICLE
        IV

        INDEMNIFICATION AND CONTRIBUTION

   

  4.1 Indemnification.

   

  4.1.1 The Company agrees to indemnify, to the
    extent permitted by law, each Holder of Registrable Securities, its officers and directors and each person who controls such Holder
    (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’
    fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or
    preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required
    to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained
    in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the
    Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities
    Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

   

  4.1.2 In connection with any Registration Statement
    in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information
    and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and,
    to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls
    the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including
    without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration
    Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact
    required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue
    statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein;
    provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of
    Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to
    the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders
    of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters
    (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the
    Company.

   

  
  
    	 

  

  
     

  

  
    

  4.1.3 Any person entitled to indemnification herein
    shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided
    that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such
    failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment
    a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying
    party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed,
    the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent
    (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the
    defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for all parties
    indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a
    conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
    No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any
    settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party
    pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the
    claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

   

  4.1.4 The indemnification provided for under this
    Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or
    any officer, director or controlling person of such indemnified party and shall survive the transfer of securities.

   

  4.1.5 If the indemnification provided under this
    Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect
    of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying
    the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims,
    damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party
    and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
    and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue
    or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates
    to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s
    relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however,
    that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received
    by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses
    or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1,
    4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection
    with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant
    to this subsection 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take
    account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of fraudulent misrepresentation
    (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5
    from any person who was not guilty of such fraudulent misrepresentation.

   

  
  
    	 

  

  
     

  

  
    

  ARTICLE
        V

        STOCKHOLDER RIGHTS

   

  5.1 Sponsor Nomination Right. Subject
    to the terms and conditions of this Agreement, at any time and from time to time on or after the date that the Company consummates
    a Business Combination and for so long as the Sponsor holds any Registrable Securities:

   

  5.1.1 The Sponsor shall have the right, but not
    the obligation, to designate three (3) individuals to be appointed or nominated, as the case may be, for election to the Board
    (including any successor, each, a “Nominee”) by giving written notice to the Company on or before the
    time such information is reasonably requested by the Board or the Nominating and Corporate Governance Committee of the Board, as
    applicable, for inclusion in a proxy statement for a meeting of stockholders.

   

  5.1.2 The Company will, as promptly as practicable,
    use its best efforts to take all necessary and desirable actions (including, without limitation, calling special meetings of the
    Board and the stockholders and recommending, supporting and soliciting proxies) so that the applicable number of Sponsor Directors
    is serving on the Board at all times during which the nomination rights provided in Section 5.1.1 are applicable.

   

  5.1.3 The Company shall, to the fullest extent
    permitted by applicable law, use its best efforts to take all actions necessary to ensure that: (i) each Nominee is included in
    the Board’s slate of nominees to the stockholders of the Company for each election of directors; and (ii) each Nominee is
    included in the proxy statement prepared by management of the Company in connection with soliciting proxies for every meeting of
    the stockholders of the Company called with respect to the election of members of the Board, and at every adjournment or postponement
    thereof, and on every action or approval by written consent of the stockholders of the Company or the Board with respect to the
    election of members of the Board.

   

  5.1.4 If a vacancy occurs because of the death,
    disability, disqualification, resignation, or removal of a Sponsor Director or for any other reason during the period in which
    rights provided in Section 5.1.1 are applicable, the Sponsor shall be entitled to designate such person’s successor, and
    the Company will, as promptly as practicable following such designation, use its best efforts to take all necessary and desirable
    actions, to the fullest extent permitted by law, within its control such that such vacancy shall be filled with such successor
    Nominee.

   

  5.1.5 If a Nominee is not elected because of such
    Nominee’s death, disability, disqualification, withdrawal as a nominee or for any other reason, the Sponsor shall be entitled
    to designate promptly another Nominee and the Company will take all necessary and desirable actions within its control such that
    the director position for which such Nominee was nominated shall not be filled pending such designation.

   

  5.1.6 As promptly as reasonably practicable following
    the request of any Sponsor Director, the Company shall enter into an indemnification agreement with such Sponsor Director, in the
    form entered into with the other members of the Board. The Company shall pay the reasonable, documented out-of-pocket expenses
    incurred by the Sponsor Director in connection with his or her services provided to or on behalf of the Company, including attending
    meetings or events attended explicitly on behalf of the Company at the Company’s request.

   

  5.1.7 The Company shall (i) purchase directors’
    and officers’ liability insurance in an amount determined by the Board to be reasonable and customary and (ii) for so long
    as a Sponsor Director serves as a Director of the Company, maintain such coverage with respect to such Sponsor Director; provided
      that upon removal or resignation of such Sponsor Director for any reason, the Company shall take all actions reasonably necessary
    to extend such directors’ and officers’ liability insurance coverage for a period of not less than six years from any
    such event in respect of any act or omission occurring at or prior to such event.

   

  5.1.8 For so long as a Sponsor Director serves
    as a director of the Company, the Company shall not amend, alter or repeal any right to indemnification or exculpation covering
    or benefiting any director nominated pursuant to this Agreement as and to the extent consistent with applicable law, whether such
    right is contained in the Company’s certificate of incorporation or bylaws, each as amended, or another document (except
    to the extent such amendment or alteration permits the Company to provide broader indemnification or exculpation rights on a retroactive
    basis than permitted prior thereto).

   

  
  
    	 

  

  
     

  

  
    

  5.1.9 Any Nominee will be subject to the Company’s
    customary due diligence process, including its review of a completed questionnaire and a background check. Based on the foregoing,
    the Company may object to any Nominee provided (a) it does so in good faith, and (b) such objection is based upon any of the following:
    (i) such Nominee was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic
    violations and other minor offenses), (ii) such Nominee was the subject of any order, judgment, or decree not subsequently reversed,
    suspended or vacated of any court of competent jurisdiction, permanently or temporarily enjoining such proposed director from,
    or otherwise limiting, the following activities: (A) engaging in any type of business practice, or (B) engaging in any activity
    in connection with the purchase or sale of any security or in connection with any violation of federal or state securities laws,
    (iii) such Nominee was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal
    or state authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity
    described in clause (ii)(B), or to be associated with persons engaged in such activity, (iv) such proposed director was found by
    a court of competent jurisdiction in a civil action or by the Commission to have violated any federal or state securities law,
    and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended or vacated, or
    (v) such proposed director was the subject of, or a party to any federal or state judicial or administrative order, judgment, decree,
    or finding, not subsequently reversed, suspended or vacated, relating to a violation of any federal or state securities laws or
    regulations. In the event the Board reasonably finds the Nominee to be unsuitable based upon one or more of the foregoing clauses
    (i) through (v) and reasonably objects to the identified director, the Sponsor shall be entitled to propose a different nominee
    to the Board within 30 calendar days of the Company’s notice to Sponsor of its objection to the Nominee and such replacement
    Nominee shall be subject to the review process outlined above.

   

  5.1.10 The Company shall take all necessary action
    to cause a Sponsor Director chosen by the Sponsor to be elected to the board of directors (or similar governing body) of each material
    operating subsidiary of the Company to the extent requested by the Sponsor. Such Sponsor Director shall have the right to attend
    (in person or remotely) any meetings of the board of directors (or similar governing body or committee thereof) of each subsidiary
    of the Company.

   

  5.2 Board Observer Rights. For so long
    as Amy Zipper and Brett Thomas (each, an “Observer”) are employed as executive officers of the Company
    and subject to the rights of HumanCo LLC and CAVU Venture Partners III, LP, respectively, to select replacements in each of their
    sole discretion, the Company will permit each Observer to attend meetings of the Board as a non-voting observer, and
    will give such individual notice of such meetings at the same time and in the same manner as notice to the Board. Each Observer
    shall be entitled to concurrent receipt of any materials provided to the Board, subject to customary confidentiality obligations.
    No Observer shall have any fiduciary or similar duty to, or liability for any debt or obligation of, the Company or to or of any
    other entity or person whatsoever as a result of this Section 5.2 or any exercise of, or failure to exercise,
    the rights of an Observer under this Agreement.

   

  ARTICLE
        VI

        MISCELLANEOUS

   

  6.1 Notices. Any notice or communication
    under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified,
    postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing
    evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or
    communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served,
    sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the
    case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as
    it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused
    by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to:
    P.O. Box 90608, Austin, TX 78709, Attention: Ross Berman, with copy to: Ropes & Gray LLP, Ropes & Gray LLP, 1211 Avenue
    of the Americas, New York, NY 10036, Attention: Paul Tropp, and, if to any Holder, at such Holder’s address or facsimile
    number as set forth in the Company’s books and records. Any party may change its address for notice at any time and from
    time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days
    after delivery of such notice as provided in this Section 6.1.

   

  
  
    	 

  

  
     

  

  
    

  6.2 Assignment; No Third Party Beneficiaries.

   

  6.2.1 This Agreement and the rights, duties and
    obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

   

  6.2.2 Prior to the expiration of the Founder Shares
    and CAVU Shares Lock-Up Period or the Private Placement and CAVU Warrants Lock-Up Period, as the case may be, no Holder may assign
    or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with
    a transfer of Registrable Securities by such Holder to a Permitted Transferee, but only if such Permitted Transferee agrees to
    become bound by the transfer restrictions set forth in this Agreement, the Insider Letter and other applicable agreements.

   

  6.2.3 This Agreement and the provisions hereof
    shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the
    Holders, which shall include Permitted Transferees.

   

  6.2.4 This Agreement shall not confer any rights
    or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 6.2
    hereof.

   

  6.2.5 No assignment by any party hereto of such
    party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company
    shall have received (i) written notice of such assignment as provided in Section 6.1 hereof and (ii) the written agreement
    of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which
    may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as
    provided in this Section 6.2 shall be null and void.

   

  6.3 Severability. This Agreement shall
    be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability
    of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision,
    the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid
    or unenforceable provision as may be possible that is valid and enforceable.

   

  6.4 Counterparts. This Agreement may
    be executed in counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together
    shall constitute one and the same instrument. The words “execution,” “signed,” “signature,”
    and words of like import in this Agreement or in any other certificate, agreement or document related to this Agreement shall include
    images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, “pdf,”
    “tif” or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign).
    The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated,
    sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as
    a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law,
    including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records
    Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act
    or the Uniform Commercial Code.

   

  6.5 Entire Agreement. This Agreement
    (including all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto)
    constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous
    agreements, representations, understandings, negotiations and discussions between the parties, whether oral or written.

   

  6.6 Governing Law; Venue. NOTWITHSTANDING
    THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT
    SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED
    INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II)
    THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE
    OF NEW YORK.

   

  
  
    	 

  

  
     

  

  
    

  6.7 Waiver of Trial by Jury. Each party
    hereby irrevocably and unconditionally waives the right to a trial by jury in any action, suit, counterclaim or other proceeding
    (whether based on contract, tort or otherwise) arising out of, connected with or relating to this Agreement, the transactions contemplated
    hereby, or the actions of the Sponsor in the negotiation, administration, performance or enforcement hereof.

   

  6.8 Amendments and Modifications. Upon
    the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time
    in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any
    of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing,
    any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the
    shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall
    require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto
    or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall
    operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies
    under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or
    thereunder by such party.

   

  6.9 Titles and Headings. Titles and headings
    of sections of this Agreement are for convenience only and shall not affect the construction of any provision of this Agreement.

   

  6.10 Remedies Cumulative. In the event
    that the Company fails to observe or perform any covenant or agreement to be observed or performed under this Agreement, the Holders
    may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term
    contained in this Agreement or for an injunction against the breach of any such term or in aid of the exercise of any power granted
    in this Agreement or to enforce any other legal or equitable right, or to take any one or more of such actions, without being required
    to post a bond. None of the rights, powers or remedies conferred under this Agreement shall be mutually exclusive, and each such
    right, power or remedy shall be cumulative and in addition to any other right, power or remedy, whether conferred by this Agreement
    or now or hereafter available at law, in equity, by statute or otherwise.

   

  6.11 Other Registration Rights. The Company
    represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to
    register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company
    for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants
    that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the
    event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

   

  6.12 Term. This Agreement shall terminate
    upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the Registrable
    Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section
    4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (B)
    the Holders of all of the Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar
    provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions of
    Section 3.5 and Article IV shall survive any termination.

   

  [SIGNATURE PAGES FOLLOW]

   

  
  
    	 

  

  
     

  

  
   

  IN WITNESS WHEREOF, the undersigned have
    caused this Agreement to be executed as of the date first written above.

   

  	 	COMPANY:
	 	 
	 	HUMANCO ACQUISITION CORP.
	 	 
	 	By: 	/s/ Amy Zipper        
	 	Name: Amy Zipper
	 	Title:   Chief Operating Officer
	 	 
	 	HOLDERS:
	 	 
	 	HUMANCO ACQUISITION HOLDINGS, LLC
	 	 
	 	By: 	/s/ Ross Berman
	 	Name: Ross Berman
	 	Title:   Manager
	 	 
	 	HMCO ACQUISITION, LLC
	 	 
	 	By: 	/s/ Jason H. Karp
	 	Name: Jason H. Karp 
	 	Title:   Manager
	 	 
	 	CAVU VENTURE PARTNERS III, LP
	 	 
	 	By: CAVU Venture Partners GP III, LP
	 	Its: General Partner
	 	 
	 	By: CAVU Venture Partners GP III, LLC
	 	Its: General Partner
	 	 
	 	By: 	Brett Thomas
	 	Name: Brett Thomas
	 	Title:  Manager

   

  	 	/s/ Katrina Cole
	 	Katrina Cole
	 	 
	 	/s/ John Foraker
	 	John Foraker
	 	 
	 	/s/ Dean Hollis
	 	Dean Hollis
	 	 
	 	/s/ Brian Kelley
	 	Brian Kelley
	 	 
	 	/s/ Ross Berman
	 	Ross Berman

   

  [Signature Page to Registration and Stockholder
    Rights Agreement]

   

  
  
    	 

  

  
     

  

  
    

  	 	/s/ Amy Zipper
	 	Amy Zipper
	 	 
	 	/s/ Brian Locklear
	 	Brian Locklear

   

  [Signature Page to Registration and Stockholder
    Rights Agreement]Exhibit 10.5

   

  December 8, 2020

   

  HumanCo Acquisition Corp.

  P.O. Box 90608

  Austin, TX 78709

   

  Re: Initial Public Offering

   

  Ladies and Gentlemen:

   

  This letter (this “Letter Agreement”)
    is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
    to be entered into by and between HumanCo Acquisition Corp., a Delaware corporation (the “Company”),
    and Citigroup Global Markets Inc., as underwriter (the “Underwriter”), relating to an underwritten initial
    public offering (the “Public Offering”) of 25,000,000 of the Company’s units (including up to 3,750,000
    units that may be purchased by the Underwriter to cover over-allotments, if any) (the “Units”), each
    comprising one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”),
    and one-half of one redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof
    to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public
    Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”), filed
    by the Company with the U.S. Securities and Exchange Commission (the “Commission”) and the Company has
    applied to have the Units listed on The Nasdaq Capital Market. Certain capitalized terms used herein are defined in paragraph 11
    hereof.

   

  In order to induce the Company and the Underwriter to enter into
    the Underwriting Agreement and to proceed with the Public Offering, and for other good and valuable consideration, the receipt
    and sufficiency of which are hereby acknowledged, each of HumanCo Acquisition Holdings, LLC (the “Sponsor”),
    HMCO Acquisition, LLC (“HumanCo SPV”), CAVU Venture Partners III, LP (“CAVU”)
    and the undersigned individuals, each of whom is a member of the Company’s board of directors and/or management team (each,
    an “Insider” and collectively, the “Insiders”), hereby agrees with the Company
    as follows:

   

  		1.	The Sponsor, HumanCo SPV, CAVU and each Insider hereby agrees that in the event that the Company fails to consummate a Business
          Combination within 24 months from the closing of the Public Offering, or such later period approved by the Company’s stockholders
          in accordance with the Company’s amended and restated certificate of incorporation (the “Charter”),
          the Sponsor, HumanCo SPV, CAVU and each Insider shall take all reasonable steps to cause the Company to (i) cease all operations
          except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 Business Days thereafter,
          subject to lawfully available funds therefor, redeem 100% of the Common Stock sold as part of the Units in the Public Offering
          (the “Offering Shares”) and the Common Stock sold as part of the CAVU Units (the “CAVU Shares”),
          at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as defined below), including
          interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income
          taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Offering Shares
          and CAVU Shares, which redemption will completely extinguish all Public Stockholders’ and holders of CAVU Shares’ rights
          as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)
          as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders
          and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under
          Delaware law to provide for claims of creditors and other requirements of applicable law. The Sponsor, HumanCo SPV, CAVU and each
          Insider agrees not to propose any amendment to the Charter to (a) modify the substance or timing of the Company’s obligation
          to allow redemption in connection with a Business Combination or the Company’s obligation to redeem 100% of the Offering
          Shares and CAVU Shares if the Company does not complete a Business Combination within the time period set forth in the Charter
          or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity,
          unless the Company provides Public Stockholders with the opportunity to redeem their shares of Common Stock upon approval of any
          such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (excluding
          any amounts then on deposit in the Trust Account that are allocable to the CAVU Shares), including interest earned on the funds
          held in the Trust Account (which interest shall be net of taxes payable and excluding any interest earned on the funds held in
          the Trust Account that are allocable to the CAVU Shares) and not previously released to the Company to pay its franchise and income
          taxes, divided by the number of then outstanding Offering Shares.

   

  
  
    	 

  

  
     

  

  
    

  The Sponsor, HumanCo SPV, CAVU and each Insider acknowledges
    that, with respect to the Founder Shares held by it, him or her, it, he or she has no right, title, interest or claim of any kind
    in or to any monies held in the Trust Account as a result of any liquidation of the Company, it being understood that CAVU makes
    no such acknowledgement with respect to the CAVU Shares in the event of any liquidation of the Company. The Sponsor, HumanCo SPV,
    CAVU and each Insider hereby agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in
    connection with such proposed Business Combination, it, he or she shall vote any shares of Capital Stock (whether purchased before,
    during or after the Public Offering, including in open market and privately negotiated transactions) owned by it, him or her in
    favor of any proposed Business Combination. The Sponsor, HumanCo SPV, CAVU and each Insider hereby further waives, with respect
    to any shares of Capital Stock held by it, him or her (including, for the avoidance of doubt, the CAVU Shares), if any, any redemption
    rights it, he or she may have in connection with the consummation of a Business Combination, including, without limitation, any
    such rights available in the context of (i) a stockholder vote to approve such Business Combination, or (ii) a stockholder vote
    to approve an amendment to the Charter to (a) modify the substance or timing of the Company’s obligation to allow redemption
    in connection with a Business Combination or to redeem 100% of the Offering Shares and CAVU Shares if the Company does not complete
    a Business Combination within the time period set forth in the Charter or (b) with respect to any other provision relating to stockholders’
    rights or pre-initial Business Combination activity (although the Sponsor, HumanCo SPV, CAVU and the Insiders shall be entitled
    to liquidation rights with respect to any Offering Shares and CAVU Shares it or they hold if the Company fails to consummate a
    Business Combination within the time period set forth in the Charter). If the Company engages in a tender offer in connection with
    any proposed Business Combination, the Sponsor, HumanCo SPV, CAVU and each Insider agrees that it, he or she will not seek to sell
    its, his or her shares of Capital Stock to the Company in connection with such tender offer.

   

  		2.	The undersigned acknowledges and agrees that prior to entering into a definitive agreement for a Business Combination or subsequent
          transaction with a target business that is affiliated with the undersigned or any other Insiders of the Company or their affiliates,
          such transaction must be approved by a majority of the Company’s disinterested independent directors and the Company, or
          a committee of independent directors, must, to the extent required by applicable law or based upon the direction of the Company’s
          board of directors or a committee thereof, obtain an opinion from an independent investment banking firm or another entity that
          commonly renders valuation opinions that such Business Combination or transaction is fair to the Company from a financial point
          of view.

   

  		3.	During the period commencing on the date of the Underwriting Agreement and ending 180 days after such date, the Sponsor, HumanCo
          SPV, CAVU and each Insider shall not, without the prior written consent of the Underwriter, (i) sell, offer to sell, contract or
          agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly,
          any Units, CAVU Units, shares of Common Stock, Founder Shares, Warrants, Private Placement Warrants, CAVU Warrants or any securities
          convertible into, or exercisable or exchangeable for, shares of Common Stock owned by it, him or her, (ii) establish or increase
          a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities
          Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission
          promulgated thereunder, with respect to any Units, CAVU Units, shares of Common Stock, Founder Shares, Warrants, Private Placement
          Warrants, CAVU Warrants or any securities convertible into, or exercisable or exchangeable for, shares of Common Stock (but excluding
          Units and shares of Common Stock purchased in the Public Offering or thereafter) owned by it, him or her, (iii) enter into
          any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of
          any Units, CAVU Units, shares of Common Stock, Founder Shares, Warrants, Private Placement Warrants, CAVU Warrants or any securities
          convertible into, or exercisable or exchangeable for, shares of Common Stock owned by it, him or her, whether any such transaction
          is to be settled by delivery of such securities, in cash or otherwise, or (iv) publicly announce any intention to effect any transaction
          specified in clause (i) , (ii) or (iii). The provisions of this paragraph will not apply if the release or waiver is effected solely
          to permit a transfer not for consideration and the transferee has agreed in writing to be bound by the same terms described in
          this Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.

   

  
  
    	2 

  

  
     

  

  
    

  		4.	In the event of the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination
          within the time period set forth in the Charter, the Sponsor (the “Indemnitor”), which for purposes of
          clarification shall not extend to any shareholders, members or managers of the Sponsor, or any of the other undersigned, agrees
          to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including,
          but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any
          litigation, whether pending or threatened) to which the Company may become subject as a result of any claim by (i) any third party
          for services rendered or products sold to the Company or (ii) any prospective target business with which the Company has entered
          into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement (a “Target”);
          provided, however, that such indemnification of the Company by the Indemnitor (x) shall apply only to the extent
          necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent public
          accountants) or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to below the lesser
          of (i) $10.00 per Offering Share and CAVU Share and (ii) the actual amount per Offering Share and CAVU Share held in the Trust
          Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Offering Share and CAVU Share is then held
          in the Trust Account due to reductions in the value of the trust assets, less interest earned on the funds in the Trust Account
          which may be withdrawn to pay franchise and income taxes, (y) shall not apply to any claims by a third party or a Target which
          executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) and
          (z) shall not apply to any claims under the Company’s indemnity of the Underwriter against certain liabilities, including
          liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Indemnitor shall
          have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15
          days following written receipt of notice of the claim to the Indemnitor, the Indemnitor notifies the Company in writing that it
          shall undertake such defense.

   

  		5.	To the extent that the Underwriter does not exercise its over-allotment option to purchase up to an additional 3,750,000 Units
          within 45 days from the date of the Prospectus (and as further described in the Prospectus) in full, the Sponsor agrees to forfeit,
          at no cost, a number of Founder Shares in the aggregate equal to 937,500 multiplied by a fraction (i) the numerator of which
          is 3,750,000 minus the number of Units purchased by the Underwriter upon the exercise of its over-allotment option, and (ii) the
          denominator of which is 3,750,000. For clarity, the forfeiture shall yield the result that the Initial Stockholders will own an
          aggregate of 20% of the Company’s issued and outstanding shares of Capital Stock after the Public Offering (excluding the
          CAVU shares and assuming that the Initial Stockholders do not purchase any Units in the Public Offering).

   

  		6.	The Sponsor, HumanCo SPV, CAVU and each Insider hereby agrees and acknowledges that: (i) the Underwriter and the Company would
          be irreparably injured in the event of a breach by such Sponsor, HumanCo SPV, CAVU or an Insider of its, his or her obligations
          under paragraphs 1, 2, 3, 4, 5, 6, 7(a), 7(b) and, solely as to each D&O Insider, 8, as applicable, of this Letter Agreement,
          (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to injunctive
          relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

   

  
  
    	3 

  

  
     

  

  
    

  		7.	(a)       The Sponsor, HumanCo SPV, CAVU and each Insider agrees that it, he or she shall
          not Transfer any Founder Shares or CAVU Shares (or shares of Common Stock issuable upon conversion thereof) until the earlier of
          (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s
          initial Business Combination, (x) if the last reported sale price of the Common Stock equals or exceeds $12.00 per share (as
          adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
          30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date
          on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that
          results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities
          or other property (the “Founder Shares Lock-up Period”).

   

  (b)       The
    Sponsor, HumanCo SPV, CAVU and each Insider agrees that it, he or she shall not Transfer any Private Placement Warrants or CAVU
    Warrants (or shares of Common Stock issued or issuable upon the exercise thereof) until 30 days after the completion of the
    Company’s initial Business Combination (the “Private Placement Warrants Lock-up Period”, together
    with the Founder Shares Lock-up Period, the “Lock-up Periods”).

   

  (c)       Notwithstanding
    the provisions set forth in paragraphs 7(a) and (b), Transfers of the Founder Shares, CAVU Shares, Private Placement Warrants,
    CAVU Warrants and shares of Common Stock issued or issuable upon the exercise or conversion thereof and, with respect to the Founder
    Shares, Private Placement Warrants and shares of Common Stock issued or issuable upon the exercise or conversion thereof, that
    are held by the Sponsor, HumanCo SPV, CAVU, any Insider or any of their permitted transferees (that have complied with this paragraph 7(c)),
    are permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s
    officers or directors, the Sponsor, any members of the Sponsor, any affiliates of the Sponsor or CAVU, or any affiliates of such
    members and funds and accounts advised by such members or any limited partners of any such funds that are invested in the Sponsor
    or the limited partners of CAVU; (b) in the case of an individual, by gift to a member of such individual’s immediate family
    or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual
    or to a charitable organization; (c) in the case of an individual, by virtue of the laws of descent and distribution upon death
    of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private
    sales or transfers made in connection with the consummation of an initial Business Combination at prices no greater than the price
    at which the Founder Shares, CAVU Shares, Private Placement Warrants, CAVU Warrants or shares of Common Stock were originally purchased;
    (f) to an entity that is an affiliate of the holder; (g) in the event of the Company’s liquidation prior to the completion
    of an initial Business Combination; (h) by virtue of the laws of the State of Delaware or the Sponsor’s limited liability
    company agreement upon dissolution of the Sponsor; (i) in the event of the Company’s liquidation, merger, capital stock exchange,
    reorganization or other similar transaction which results in all of the Company’s stockholders having the right to exchange
    their shares of Common Stock for cash, securities or other property subsequent to the completion of an initial Business Combination;
    or (j) to the Company for no value for cancellation in connection with the consummation of the initial Business Combination; provided,
    however, that, in the case of clauses (a) through (f) or (h), these permitted transferees must enter into a written agreement
    with the Company agreeing to be bound by the transfer restrictions in this paragraph 7(c) and the other restrictions contained
    in this Letter Agreement.

   

  
  
    	4 

  

  
     

  

  
    

  		8.	Each of the Insiders who is or is nominated to be a director or officer of the Company (each, a “D&O Insider”)
          agrees to serve in such capacity until the earlier of the consummation by the Company of an initial Business Combination, the liquidation
          of the Company, or his or her removal, death or incapacity. The Sponsor, HumanCo SPV, CAVU and each D&O Insider represents
          and warrants that it, he or she has never been suspended or expelled from membership in any securities or commodities exchange
          or association or had a securities or commodities license or registration denied, suspended or revoked. Each D&O Insider’s
          biographical information furnished to the Company (including any such information included in the Prospectus) is true and accurate
          in all material respects and does not omit any material information with respect to the D&O Insider’s background and
          contains all of the information required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities
          Act. Each D&O Insider’s questionnaire furnished to the Company and the Underwriter is true and accurate in all material
          respects. Each D&O Insider represents and warrants that: it, he or she is not subject to or a respondent in any legal action
          for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the
          offering of securities in any jurisdiction; it, he or she has never been convicted of, or pleaded guilty to, any crime (i) involving
          fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any
          dealings in any securities; and it, he or she is not currently a defendant in any such criminal proceeding.

   

  		9.	Except as disclosed in the Prospectus, neither the Sponsor, HumanCo SPV, CAVU nor any Insider, nor any affiliate of the Sponsor,
          HumanCo SPV, CAVU or any Insider, shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies
          in respect of any repayment of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate,
          the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is).

   

  		10.	The Company, the Sponsor, HumanCo SPV, CAVU and each Insider represents and warrants, severally and not jointly, that it, he
          or she has full right and power, without violating any agreement to which it, he or she is bound (including, without limitation,
          any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and,
          as applicable, to serve as an officer and/or director on the board of directors of the Company and hereby consents to being named
          in the Prospectus as an officer and/or director of the Company.

   

  		11.	As used herein, (i) “Business Combination” shall mean a merger, capital stock exchange, asset acquisition,
          stock purchase, reorganization or similar business combination, involving the Company and one or more businesses; (ii) “Business
              Day” means each day that is not a Saturday, Sunday or other day on which banking institutions in The City
          of New York, New York, are authorized or required by law to close; (iii) “CAVU Units” shall mean the
          units, each identical to the Units except as described in the Prospectus, that CAVU has agreed to purchase for an aggregate purchase
          price of $25,000,000, or $10.00 per unit, in a private placement that shall occur simultaneously with the consummation of the Public
          Offering; (iv) “CAVU Warrants” shall mean the warrants to purchase up to 1,250,000 shares of Common Stock
          of the Company that are included in the CAVU Units; (v) “Capital Stock” shall mean, collectively,
          the Common Stock and the Founder Shares; (vi) “Founder Shares” shall mean the 7,187,500 shares of
          the Company’s Class B common stock, par value $0.0001 per share, issued and outstanding immediately prior to the consummation
          of the Public Offering (up to 937,500 shares of which are subject to complete or partial forfeiture by the Sponsor if the over-allotment
          option is not exercised in full by the Underwriter); (vii) “Initial Stockholders” shall mean the
          Sponsor and any Insider that holds Founder Shares prior to the consummation of the Public Offering; (viii) “Private
              Placement Warrants” shall mean the Warrants to purchase up to 7,325,000 shares of Common Stock of the Company (or
          8,075,000 shares of Common Stock if the over-allotment option is exercised in full by the Underwriter) that the Sponsor has agreed
          to purchase for an aggregate purchase price of $7,325,000 (or $8,075,000 if the over-allotment option is exercised in full by the
          Underwriter), or $1.00 per Warrant, in a private placement that shall occur simultaneously with the consummation of the Public
          Offering; (ix) “Public Stockholders” shall mean the holders of the Offering Shares; (x) “Trust
              Account” shall mean the trust account into which the net proceeds of the Public Offering, the sale of the CAVU Units
          and certain proceeds from the sale of the Private Placement Warrants shall be deposited; and (xi) “Transfer”
          shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase
          or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
          or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange
          Act, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap
          or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
          whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement
          of any intention to effect any transaction specified in clause (a) or (b).

   

  
  
    	5 

  

  
     

  

  
    

  		12.	The Company will maintain an insurance policy or policies providing directors’ and officers’ liability insurance,
          and each D&O Insider shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent
          of the coverage available for any of the Company’s directors or officers.

   

  		13.	This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
          hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
          to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement
          may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except
          by a written instrument executed by all parties hereto.

   

  		14.	No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the
          prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual
          and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding
          on the Company, the Sponsor and each Insider and their respective successors, heirs and assigns and permitted transferees.

   

  		15.	Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties
          hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise
          or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall
          be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and
          permitted transferees.

   

  		16.	This Letter Agreement may be executed in any number of original, facsimile or other electronic counterparts and each of such
          counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and
          the same instrument.

   

  		17.	This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall
          not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu
          of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter
          Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

   

  		18.	This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York,
          without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
          The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this
          Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit
          to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive
          jurisdiction and venue or that such courts represent an inconvenient forum.

   

  
  
    	6 

  

  
     

  

  
    

  		19.	Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall
          be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested),
          by hand delivery or facsimile or e-mail transmission.

   

  		20.	This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of
          the Company; provided that paragraph 4 of this Letter Agreement shall survive such liquidation.

   

  [Remainder of page intentionally left blank]

   

  
  
    	7 

  

  
     

  

  
   

  	 	Sincerely,
	 	 
	 	HUMANCO ACqusition HOLDINGS, LLC
	 	 	 
	 	By:	/s/ Ross Berman
	 	 	Name:  Ross Berman
	 	 	Title:   Manager

   

  	 	HMCO ACQUISITION, LLC
	 	 	 
	 	By: 	/s/ Jason H. Karp        
	 	Name:  Jason H. Karp
	 	Title: Manager
	 	 	 
	 	cavu venture partners iii, lp
	 	 
	 	By: CAVU Venture Partners GP III, LP
	 	Its: General Partner
	 	 
	 	By: CAVU Venture Partners GP III, LLC
	 	Its: General Partner
	 	 	 
	 	By: 	/s/ Brett Thomas     
	 	Name:  Brett Thomas
	 	Title:    Manager

   

  	 	/s/ Jason H. Karp
	 	Jason H. Karp
	 	 
	 	/s/ Ross Berman
	 	Ross Berman
	 	 
	 	/s/ Brett Thomas
	 	Brett Thomas
	 	 
	 	/s/ Amy Zipper
	 	Amy Zipper
	 	 
	 	/s/ Brian Locklear
	 	Brian Locklear
	 	 
	 	/s/ Rohan Oza
	 	Rohan Oza
	 	 
	 	/s/ Katrina Cole
	 	Katrina Cole

   

  [Signature
      Page to Letter Agreement]

   

  
  
    	 

  

  
     

  

  
    

  	 	/s/ John Foraker
	 	John Foraker
	 	 
	 	/s/ Dean Hollis
	 	Dean Hollis
	 	 
	 	/s/ Brian Kelley
	 	Brian Kelley

   

  	Acknowledged and Agreed:	 
	 	 
	Humanco acquisition corp.	 
	 	 	 
	By:	/s/ Amy Zipper	 
	 	Name: Amy Zipper	 
	 	Title:   Chief Operating Officer	 

   

  [Signature
      Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]